Patient factors associated with COVID-19 loss of taste or smell patient factors in smell/taste loss COVID-19.

ACE2 COVID‐19 SARS‐CoV‐2 smell taste

Journal

Laryngoscope investigative otolaryngology
ISSN: 2378-8038
Titre abrégé: Laryngoscope Investig Otolaryngol
Pays: United States
ID NLM: 101684963

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 27 05 2022
revised: 07 07 2022
accepted: 08 08 2022
entrez: 22 12 2022
pubmed: 23 12 2022
medline: 23 12 2022
Statut: epublish

Résumé

Dysfunction in smell or taste is well recognized phenomenon in patients infected with SARS-CoV-2. This study aimed to quantify the incidence and associated co-morbidities of reported olfactory or gustatory dysfunction in patients who tested positive for SARS-CoV-2. From March 23, 2020 through July 31, 2020, 192,683 patients were tested for SARS-CoV-2 at Mayo Clinic. These patients with a positive test were contacted via telephone by physicians at Mayo Clinic and information gathered on patient demographics, comorbidities, symptoms and clinical risk stratification based on these factors. Two thousand two hundred and fifty patients tested positive for SARS-CoV-2 (1.2%). Six hundred and sixty-seven (29.6%) of these patients reported loss of smell or taste. Factors found to be correlated with reporting loss of smell or taste on multivariate analysis were: younger age, female sex, or symptoms of chest pain or tightness, cough, or headache and lower clinical risk category. Coronary artery disease (CAD) was associated with not reporting loss of taste or smell. Of 2250 patients testing positive for SARS-CoV-2 at Mayo Clinic, 667 reported loss of taste and smell. Patients who reported loss of smell or taste were younger, female and more likely to report cough, chest pain, headache, or history of chronic obstructive pulmonary disease (COPD), but overall had fewer high-risk comorbidities. Those who were older, male, and a reported history of CAD were less likely to report chemosensory dysfunction. Our data are the largest single institution data reporting COVID-19 associated loss of smell or taste, and the first to associate COPD and CAD as factors that affect rates of reported chemosensory dysfunction. IIB.

Identifiants

pubmed: 36544937
doi: 10.1002/lio2.911
pii: LIO2911
pmc: PMC9764767
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1688-1694

Informations de copyright

© 2022 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley Periodicals LLC on behalf of The Triological Society.

Déclaration de conflit d'intérêts

No conflicts of interest for any of the authors.

Références

Med Mal Infect. 2020 Aug;50(5):436-439
pubmed: 32305563
Otolaryngol Pol. 2020 Aug 6;75(2):1-5
pubmed: 33724231
ACS Chem Neurosci. 2020 Oct 7;11(19):2944-2961
pubmed: 32870641
Eur Respir J. 2020 Sep 24;56(3):
pubmed: 32817004
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Am J Otolaryngol. 2020 Nov - Dec;41(6):102721
pubmed: 32977063
Mol Ther Methods Clin Dev. 2020 May 22;18:1-6
pubmed: 32537478
Am J Otolaryngol. 2021 Nov-Dec;42(6):103068
pubmed: 33940252
Clin Exp Allergy. 2020 Dec;50(12):1313-1324
pubmed: 32975865
J Med Virol. 2022 Oct;94(10):4762-4775
pubmed: 35672249
Mayo Clin Proc. 2020 Aug;95(8):1621-1631
pubmed: 32753137
Otolaryngol Clin North Am. 2018 Aug;51(4):815-825
pubmed: 30001793
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
OTO Open. 2020 Sep 11;4(3):2473974X20957975
pubmed: 32964177
Head Neck. 2020 Jun;42(6):1252-1258
pubmed: 32342566
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Nat Commun. 2020 Oct 28;11(1):5453
pubmed: 33116139
Int J Cardiol. 2015 Jan 20;179:46-8
pubmed: 25464408
Clin Sci (Lond). 2013 Jan;124(2):65-76
pubmed: 23013041
Otolaryngol Head Neck Surg. 2020 Jul;163(1):3-11
pubmed: 32369429
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950
pubmed: 32301284
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813
pubmed: 32279441
World J Otorhinolaryngol Head Neck Surg. 2018 Mar 26;4(1):84-91
pubmed: 30035266
Am J Otolaryngol. 2021 Mar-Apr;42(2):102889
pubmed: 33445036
Neurosci Lett. 2021 Mar 23;748:135694
pubmed: 33600902
Eur Respir J. 2020 May 14;55(5):
pubmed: 32269089
Laryngoscope. 2021 Apr;131(4):865-878
pubmed: 33219539

Auteurs

B Jake Johnson (BJ)

Mayo Clinic Department of Otolaryngology-Head and Neck Surgery Mayo Clinic Rochester Minnesota USA.

Bradley Salonen (B)

Mayo Clinic Department of General Internal Medicine Mayo Clinic Rochester Minnesota USA.

Thomas Jamie O'Byrne (TJ)

Mayo Clinic Department of Health Sciences Research Mayo Clinic Rochester Minnesota USA.

Garret Choby (G)

Mayo Clinic Department of Otolaryngology-Head and Neck Surgery Mayo Clinic Rochester Minnesota USA.

Ravindra Ganesh (R)

Mayo Clinic Department of General Internal Medicine Mayo Clinic Rochester Minnesota USA.

Janalee K Stokken (JK)

Mayo Clinic Department of Otolaryngology-Head and Neck Surgery Mayo Clinic Rochester Minnesota USA.

Erin K O'Brien (EK)

Mayo Clinic Department of Otolaryngology-Head and Neck Surgery Mayo Clinic Rochester Minnesota USA.

Classifications MeSH